Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.
A novel pH-sensitive interferon-β (INF-β) oral delivery system for application in multiple sclerosis.
TECFIDERA® Data Confirm Strong and Sustained Efficacy in Newly Diagnosed MS Patients and Real-World Effectiveness
ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.
Arzerra
RILUTEK®
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis.
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.
Cross-cultural Adaptation, Reliability, and Validity of the BICAMS in Brazil.
Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model.
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS) (INSPIRE)
Roche's MabThera approved for two vasculitis indications in UK
Effects of prophylactic and therapeutic teriflunomide in transcranial magnetic stimulation-induced motor-evoked potentials in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
Genzyme’s Lemtrada Recommended for Reimbursement on NHS by the National Institute for Health and Care Excellence (NICE)
TGFβ Signaling Regulates the Timing of CNS Myelination by Modulating Oligodendrocyte Progenitor Cell Cycle Exit through SMAD3/4/FoxO1/Sp1.
The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain.
NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels.
Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: Differential expression of neurotrophic and gliotrophic factors.
[Results of a comparative clinical trial of the Russian Β - interferon-1b bioanalogue (infibeta)].
The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS.
Receptos Completes Enrollment of RADIANCE Phase 3 Trial of Ozanimod in Relapsing Multiple Sclerosis
Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans.
Physicians from Accentia and Johns Hopkins University present plans for new MS drug study for Cyrevia
Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart.

Pages